Pulmonx
LUNG
$9.38
Share price
21.50%
Change (1 day)
-18.22%
Change (1 year)
Categories
Operating Margin for Pulmonx (LUNG)
Operating Margin as of May 2024 (TTM): -99.46%
According to Pulmonx's latest financial reports and stock price the company's current Operating Margin is -99.46%. At the end of 2021 the company had an Operating Margin of -99.80%.
Operating Margin history for Pulmonx from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -99.80% | 2.03% |
| 2020 | -97.82% | 56.75% |
| 2019 | -62.40% | -32.4% |
| 2018 | -92.32% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 7.17% | -107.21% | 🇺🇸 USA |
 Inari Medical
NARI | -2.74% | -97.25% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.